TUMOR-INDUCED OSTEOMALACIA (TIO)

Clinical trials for TUMOR-INDUCED OSTEOMALACIA (TIO) explained in plain language.

Never miss a new study

Get alerted when new TUMOR-INDUCED OSTEOMALACIA (TIO) trials appear

Sign up with your email to follow new studies for TUMOR-INDUCED OSTEOMALACIA (TIO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists track rare bone disease over time

Knowledge-focused Ongoing

This study aims to observe and collect long-term information from 23 patients with a rare bone-softening disease called tumor-induced osteomalacia (TIO). It will track the safety and effectiveness of a specific drug (burosumab) for those taking it, and monitor the underlying tumo…

Matched conditions: TUMOR-INDUCED OSTEOMALACIA (TIO)

Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Knowledge-focused

Last updated Mar 13, 2026 15:05 UTC

TUMOR-INDUCED OSTEOMALACIA (TIO)

Get alerted when new TUMOR-INDUCED OSTEOMALACIA (TIO) trials appear

Scientists track rare bone disease over time